This federal contract award is for the delivery of WAKIX 17.8 mg tablets to the Department of Veterans Affairs (VA) through a Firm Fixed Price Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The prime contractor is Harmony Biosciences LLC, a for-profit pharmaceutical company specializing in rare neurological diseases and sleep disorders, headquartered in Plymouth Meeting, Pennsylvania. The $10,418.14 contract has an ultimate completion date of June 18,...
The U.S. Department of Veterans Affairs (VA) awarded a $10,170 firm-fixed-price delivery order to Harmony Biosciences LLC for the pharmaceutical drug WAKIX 17.8MG 60 DOSES. This order is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. Harmony Biosciences is a for-profit pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The delivery order has a period of...
This federal contract award to Harmony Biosciences LLC is a $10,170 firm-fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration. The award is placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The...
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company, to supply WAKIX 17.8 mg tablets. The contract has a ceiling value of $10,418.14 and an ultimate completion date of September 12, 2025. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and does not have a set-aside designation, indicating open competition. Harmony Biosciences LLC is a...
This is a delivery order issued by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to Harmony Biosciences LLC for the supply of WAKIX 17.8 mg tablets. The order, valued at $10,418.14, has a completion date of June 25, 2025. Harmony Biosciences LLC is a for-profit pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract is not set aside and represents an open competition...
This federal contract award to Harmony Biosciences LLC, a pharmaceutical company, is a delivery order against the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valued at $10,170.00, this firm-fixed-price order is for the medication WAKIX 17.8 MG, which is used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The order is placed by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to...
This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The $10,170.00 firm fixed price order is for the drug WAKIX (pitolisant) and is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract. This award is not...
The U.S. Department of Veterans Affairs (VA) awarded a $10,170.00 firm-fixed-price delivery order to Harmony Biosciences LLC, a pharmaceutical company, to provide WAKIX (pitolisant) tablets. This order was placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The VA has also awarded Harmony Biosciences a $5 million Blanket Purchase Agreement and a $259,000 multiple award indefinite-delivery...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC for the provision of WAKIX (pitolisant) 17.8 mg tablets. The $5,209.07 contract has an ultimate completion date of April 1, 2025 and is issued against the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Harmony Biosciences, a for-profit pharmaceutical company that specializes in neurological and sleep disorder treatments, has previously received...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical manufacturer, to supply WAKIX (pitolisant) tablets. The order, valued at $10,170.00, is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract. Harmony Biosciences also holds a $5 million Blanket Purchase Agreement and a $259,000 multiple...